Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)

NCT00329745 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

8687

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Rotavirus

Interventions

BIOLOGICAL: Rotarix™
BIOLOGICAL: Placebo

Sponsor

GlaxoSmithKline